throbber
Proteomic Analysis of Bifidobacteriumlongum subsp.
`infantis Reveals the Metabolic Insight on Consumption
`of Prebiotics and Host Glycans
`
`Jae-Han Kim1, Hyun Joo An2, Daniel Garrido3,4, J. Bruce German4,5, Carlito B. Lebrilla4,6,
`David A. Mills3,4,5*
`
`1 Department of Food Nutrition, Chungnam National University, Yuseong-gu, Daejeon, Korea, 2 Graduate School of Analytical Science and Technology, Chungnam
`National University, Yuseong-gu, Daejeon, Korea, 3 Department of Viticulture and Enology, University of California Davis, Davis, California, United States of America,
`4 Foods for Health Institute, University of California Davis, Davis, California, United States of America, 5 Department of Food Science and Technology, University of
`California Davis, Davis, California, United States of America, 6 Department of Chemistry, University of California Davis, Davis, California, United States of America
`
`Abstract
`
`Bifidobacterium longum subsp. infantis is a common member of the intestinal microbiota in breast-fed infants and capable
`of metabolizing human milk oligosaccharides (HMO). To investigate the bacterial response to different prebiotics, we
`analyzed both cell wall associated and whole cell proteins in B. infantis. Proteins were identified by LC-MS/MS followed by
`comparative proteomics to deduce the protein localization within the cell. Enzymes involved in the metabolism of lactose,
`glucose, galactooligosaccharides, fructooligosaccharides and HMO were constitutively expressed exhibiting less than two-
`fold change regardless of the sugar used. In contrast, enzymes in N-Acetylglucosamine and sucrose catabolism were
`induced by HMO and fructans, respectively. Galactose-metabolizing enzymes phosphoglucomutase, UDP-glucose 4-
`epimerase and UTP glucose-1-P uridylytransferase were expressed constitutively, while galactokinase and galactose-1-
`phosphate uridylyltransferase, increased their expression three fold when HMO and lactose were used as substrates for cell
`growth. Cell wall-associated proteomics also revealed ATP-dependent sugar transport systems associated with consumption
`of different prebiotics. In addition, the expression of 16 glycosyl hydrolases revealed the complete metabolic route for each
`substrate. Mucin, which possesses O-glycans that are structurally similar to HMO did not induced the expression of transport
`proteins, hydrolysis or sugar metabolic pathway indicating B. infantis do not utilize these glycoconjugates.
`
`Citation: Kim J-H, An HJ, Garrido D, German JB, Lebrilla CB, et al. (2013) Proteomic Analysis of Bifidobacterium longum subsp. infantis Reveals the Metabolic
`Insight on Consumption of Prebiotics and Host Glycans. PLoS ONE 8(2): e57535. doi:10.1371/journal.pone.0057535
`
`Editor: Valerie de Cre´ cy-Lagard, University of Florida, United States of America
`
`Received August 21, 2012; Accepted January 25, 2013; Published February 26, 2013
`Copyright: ß 2013 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
`use, distribution, and reproduction in any medium, provided the original author and source are credited.
`
`Funding: This work was supported in part by the University of California Discovery Grant Program, the California Dairy Research Foundation, and National
`Institute of Health Awards R01HD061923 (C.B.L.) and R01AT007079 (D.A.M.). The research was also supported by the Converging Research Center Program
`through the Ministry of Education, Science and Technology (2011K000985 for J.H.K.). The funders had no role in study design, data collection and analysis,
`decision to publish, or preparation of the manuscript.
`
`Competing Interests: The authors have declared that no competing interests exist.
`
`* E-mail: damills@ucdavis.edu
`
`Introduction
`
`infantis)
`infantis (B.
`Bifidobacterium longum subsp.
`is a common
`member of the gastrointestinal tract (GIT) of breast-fed infants [1].
`The establishment of a bifidobacterial-dominant microbiota has
`received considerable attention regarding the development of the
`infant [2]. One potential means by which specific bifidobacteria
`succeed in colonizing the infant GIT is
`through prebiotic
`enrichment by human milk oligosaccharides (HMO). Human
`milk contains a significant amount of oligosaccharides (,15 g l21),
`in contrast to bovine or formula milk [3,4]. HMO is a term that
`collectively refers to approximately 200 different types of glycans
`with diverse structures with a length smaller than 20 units of
`carbohydrates [5,6]. These HMO are composed of hexoses (Hex)
`and N-Acetylhexosamines (HexNAc) connected through b1-3 or
`b1-4-glycosidic linkage with additional decoration of fucose (Fuc)
`and N-Acetylneuraminic acid (NeuAc). Since the human host does
`not have the enzymatic capacity to degrade these polymers, HMO
`are not considered to be metabolized by infant, and have been
`shown to arrive to the lower GIT [7]. HMO are considered part of
`
`the innate immune system being used as decoy binding sites for
`intestinal pathogens in the developing newborn [8]. Another role
`is the enrichment of bifidobacteria in the GIT [9]. While B. infantis
`and other bifidobacteria can actively utilize HMO as growth
`substrate, other intestinal bacteria such as streptococci, entero-
`cocci, E. coli and Clostridium sp. cannot use HMO as a carbon
`source, emphasizing the bifidogenic potential of HMO [10].
`Genome sequencing showed that B.
`infantis has a 40 kb gene
`cluster, termed HMO cluster I, that encodes several enzymes and
`transport systems required for HMO catabolism including a-
`fucosidase, a-sialidase, b-hexosaminidase, b-galactosidase and the
`ABC transport systems with six family 1, extracellular solute
`binding proteins (SBPs) predicted to bind oligosaccharides [11].
`These clusters of HMO-linked genes suggested a broader evolu-
`tionary partnership among B. infantis, the developing infant and
`human milk [12].
`While current commercial prebiotics used in infant formulas,
`such as fructooligosaccharides (FOS) and galactooligosaccharides
`[13], have been shown to be bifidogenic,
`these commercial
`prebiotics do not replicate the many different roles that HMO
`
`PLOS ONE | www.plosone.org
`
`1
`
`February 2013 | Volume 8 |
`
`Issue 2 | e57535
`
`Genome & Co. v. Univ. of Chicago, PGR2019-00002
`UNIV. CHICAGO EX. 2001 - 1/13
`
`

`

`carry out in the developing infant. Since B. infantis displays several
`mechanistic preferences for HMO consumption, this subspecies
`represents a useful reference with which to assess the similarity of
`commercial prebiotics to actual HMO. This in turn will aid in the
`design of more effective prebiotics for use in infant formulas as well
`as other conditions where very selective symbiotic applications
`may be useful.
`Global expression analysis of whole cell proteome by LC-MS/
`MS can provide direct information relative to biological systems
`such as metabolic pathways and regulatory networks. Despite the
`advantages of whole cell proteomics,
`it is still challenging to
`reliably identify cell wall associated (CWA) proteins due to the fact
`that these proteins are often sequestered into the insoluble material
`upon cell lysis. The lack of CWA proteins in proteomic analyses
`results in significant loss of biological information since membrane
`proteins or cell wall-anchored proteins also play important roles in
`transport, exopolysaccharide production, hydrolysis of macromo-
`lecules, and sensing of extracellular signals. Several proteomic
`methods have been developed to specifically identify the CWA
`proteins, including a 2-D gel based proteomic analysis followed by
`fractionation [14,15,16], or labeling the cell surface proteins via
`biotinylation followed by affinity capture [17,18]. An alternative
`approach is the tryptic digestion of exposed epitopes on cell surface
`proteins from intact cells in isotonic solution followed by the MS
`analysis, which often called ‘‘shaving and shedding’’ [19,20].
`In this study, we have investigated the impact of various
`prebiotics on the proteomic expression profiles of B. infantis ATCC
`15697. The microorganism was cultured with seven different
`sugars and prebiotics including HMO and mucin, and more than
`500 proteins were quantitatively identified enabling us to explore
`the entire activity cell
`in a given substrate. Importantly, we
`developed a proteomic analysis method that allowed reliable
`determination of cell wall associated proteins. Through this
`method,
`the expression of cell
`surface/membrane associated
`proteins can be determined, maximizing the total protein
`identification per cell. This has allowed a more comprehensive
`comparison of the B. infantis physiology on these prebiotics.
`
`Materials and Methods
`
`Cell Culture
`Bifidobacterium longum subsp. infantis ATCC 15697 was obtained
`from the American Type Culture Collection (Manassas, VA).
`Cultures were routinely maintained in de Mann-Rogosa-Sharp
`(MRS) medium with no carbon source, and supplemented with
`0.05% w/v L-cysteine (Sigma-Aldrich, St. Louis, MO), and 2%
`w/v of either lactose (Sigma Aldrich, MO), purified HMO [21],
`mucin from porcine stomach type III (Sigma Aldrich, MO), FOS
`(raftilose Synergy 1, Orafti, Malvern, PA), inulin (raftiline HP,
`Orafti, Malvern, PA) or GOS (Purimune, GTC Nutrition, Golden,
`CO). These experiments were performed in duplicates. Cells were
`anaerobically grown in a vinyl chamber
`(Coy Laboratory
`Products, Grass Lake, MI) at 37uC for 24 h, in an atmosphere
`consisting of 5% carbon dioxide, 5% hydrogen, and 90% nitrogen.
`Optical density was assayed using a PowerWave microplate
`spectrophotometer (BioTek Instruments, Inc., Winoosky, VT).
`Due to the significant high turbidity of medium, cell growth on
`mucin was evaluated separately. Mucin was autoclaved for 10
`minutes and added on the media (50 ml) at a final concentration of
`20 g l21. Cell growth was monitored by measuring optical density
`of cell at 600 nm in a Shimadzu UV1601 spectrophotometer
`(Shimadzu Scientific Instruments, Columbia MD). Cell cultures
`supplemented with 2% (w/v) of glucose and 2% (w/v) of HMO
`were obtained in similar conditions as control experiments.
`
`Whole Cell Proteomics of B. infants
`
`Proteomic Sample Preparation
`B. infantis cells were taken at the exponential phase of growth
`and normalized at an OD of 1.0 by dilution or concentration.
`After centrifugation to remove the spent media, 15 mL of cells
`were washed three times with phosphate buffer saline (PBS)
`followed by three more washes with urea buffer (8 M Urea/0.1 M
`Tris, pH 8.5). The cell pellet was resuspended in 600 mL of urea
`buffer, then mechanically disrupted by silica beads in a bead-
`beater (FastPrep; QBiogene, Carlsbad, CA, USA) for eight cycles
`of 30 s pulses and 30 s on ice. Upon centrifugation, the soluble
`and the insoluble fractions were stored separately at 280uC until
`further analysis.
`For proteome analysis of the soluble fraction, a sample volume
`containing 200 mg of protein was transferred to a new micro-
`centrifuge tube and precipitated by the addition of ethanol (75%
`(v/v) final) at 220uC. After centrifugation, the protein pellet was
`resuspended in 100 mL of 0.1 M Tris/1 M urea buffer (pH 8.5).
`Proteins were then digested using 5 mg of mass spectrometry grade
`trypsin (Promega, Madison, WI, USA) overnight at 37uC. In order
`to obtain the proteome of insoluble fraction, the insoluble cell
`debris pellet was resuspended in 1 mL of PBS and washed three
`times with urea buffer (8 M Urea/0.1 M Tris). The resulting pellet
`was resuspended again in 100 mL of 0.1 M Tris/1M urea buffer
`(pH 8.5) and digested with trypsin overnight. These two fractions,
`soluble and CWA, were analyzed independently. The tryptic
`peptides from two fractions were cleaned independently using
`a Macro Trap with Peptide concentration and Desalting cartridge
`(Michrom, Aurburn, CA, USA) according to the manufacturer’s
`instructions. The resultant peptides were eluted in 98% acetoni-
`trile in water and then dried prior to mass spectrometry analysis.
`
`Mass Spectrometry Analysis
`Peptides were reconstituted in water at concentrations corre-
`sponding to between 40 and 200 ng of the original protein per
`2 mL injection. Nano LC/MS and nano LC/MS/MS analyses
`were performed on an Agilent HPLC-Chip Quadrupole Time-of-
`Flight
`(Q-TOF) MS system equipped with a microwell plate
`autosampler (maintained at 6uC), capillary sample loading pump,
`nano pump, HPLC Chip/MS interface, and Agilent 6520 Q-TOF
`MS detector. The chip used consisted of a 960.075-mm i.d.
`enrichment column and a 15060.075-mm i.d. analytical column.
`For sample loading, the capillary pump delivered 0.1% formic
`acid in 3.0% acetonitrile/water (v/v) isocratically at 4.0 mL/min.
`Following sample injection, a nano pump gradient was delivered
`at 0.4 mL/min using (A) 0.1% formic acid in 3.0% acetonitrile/
`water (v/v) and (B) 0.1% formic acid in 90.0% acetonitrile/water
`(v/v). Samples were eluted with 0% B, 0.00–2.50 min; 0 to 16% B,
`2.50–10.00 min; 16 to 44% B, 10.00–30.00 min; 44 to 100% B,
`30.00–35.00 min; and 100% B, 35.00–45.00 min. This was
`followed by equilibration at 0% B, 45.01–65.00 min. The drying
`gas temperature was set at 325uC with a flow rate of 5.0 L/min
`(2.5 L of filtered nitrogen gas and 2.5 L of filtered dry compressed
`air).
`Single-stage MS spectra were acquired in the positive ionization
`mode over a mass range of m/z 400–3,000 with an acquisition
`time of 1 s per spectrum. Mass correction was enabled using
`reference masses of m/z 322.048, 622.029, 922.010, 1,221.991,
`and 1,521.971 (ESI-TOF Calibrant Mix G1969-85000, Agilent
`Technologies, Santa Clara, CA, USA).
`
`Protein Identification
`All MS/MS samples were analyzed by X! Tandem (GPM-XE
`manager, ver. 2.2.1). X! Tandem was set up to search against the
`proteome of B. infantis ATCC 15697 and common contaminant
`
`PLOS ONE | www.plosone.org
`
`2
`
`February 2013 | Volume 8 |
`
`Issue 2 | e57535
`
`Genome & Co. v. Univ. of Chicago, PGR2019-00002
`UNIV. CHICAGO EX. 2001 - 2/13
`
`

`

`proteins and searched with a fragment ion mass tolerance of
`100 ppm. Oxidation of methionine was specified as a variable
`modification in X! Tandem. The probability (log(e)) cutoff for
`peptide assignment was set at 22. For the identification, two
`conditions were required: (a) more than two unique peptides per
`protein (Puniq$2) and (b) the probability cutoff for protein less than
`26 (log(e)#26). Additional algorithms for protein identification
`validated the protein identification results by X! Tandem. All
`proteins identified by the X! Tandem were also assigned by the
`peptide prophet [22] and protein prophet algorithm [23] with the
`probability greater than 95% and 99% respectively. Since the
`experiments were performed on biological duplicates an additional
`rule was applied for the decision of protein expression. If a protein
`was identified in one of the duplicates with high probability
`(Puniq$2 and log(e)#26) then it was considered expressed. If
`a protein had a log(e) value between 26 and24 and a Puniq$2 but
`was found in both duplicates, it was also considered as expressed.
`
`Protein Quantification
`Relative amounts of protein in a sample were calculated by the
`spectral counting method [24] using the proteome on lactose
`grown cells as control. Normalized spectral abundance factor
`(NSAF), which represented the relative abundance of protein in
`a sample, was estimated from the total number of spectra used for
`the identification of protein (SpC) and the number of aminoacids of
`the protein (L). For accurate estimations, the relative amount of
`protein was calculated only if the protein NSAF value was higher
`than 1.0 or SpC of both proteins were $6.
`
`Determination of Protein Localization
`introduced that
`For
`this purpose, a scoring system was
`employed the NSAF values of each protein in the soluble and
`insoluble fraction (Table S1). If the protein was observed only at
`the insoluble fraction, or the NSAF value of that protein in the
`insoluble fraction was more than 3-fold higher than the NSAF
`value of the same protein in the soluble fraction, the protein had
`score +1. If the NSAF ratio was between 2- and 3-fold, a protein
`was given a score of +0.5. When the NSAFs values of the same
`protein in the soluble and insoluble fractions were within 2-fold
`difference, the protein was given a score of zero. If the NSAF of
`a protein at the soluble fraction was larger than that of at insoluble
`fraction, the scores were attributed using the same criteria above,
`however the values were negative. Once scores were determined,
`values from the experiments with six different carbon sources were
`averaged. If a protein had an average score between +0.5 to +1.0 it
`was classified as a CWA protein. If the average score of a protein
`was between 20.5 to 21.0, it was considered as cytosolic (CYT)
`protein (Table S2).
`
`Results
`
`Cell Growth and Overall Protein Expression Profiles
`B. infantis was able to utilize various mono and oligosaccharides
`as growth substrates. The specific cell growth rates on GOS, FOS,
`inulin, and HMO were in a range of 0.14,0.19 (hr21) which are
`similar to that of glucose and lactose (Figure S1A). Mucin is a large
`extracellular protein that is heavily glycosylated. The O-glycan
`attached on the serine residue of mucin protein is composed of N-
`Acetylgalactosamine, N-Acetylglucosamine, fucose, galactose and
`sialic acid and has similar structures to HMO. It has been reported
`that several intestinal bacteria are able to interact with the mucin
`glycans [25,26]. Using mucin as the sole carbon source (Figure
`S1B), an increase in OD600 was appreciated for B. infantis albeit
`with the high initial cell density values.
`
`Whole Cell Proteomics of B. infants
`
`identified from the soluble and
`The number of proteins
`insoluble fractions is summarized in Table S3. Between 350 and
`400 proteins were found in any individual sample grown on each
`carbon source, and 100,170 proteins were commonly observed in
`both the soluble and insoluble fractions in each sample. A sum
`total of 540 proteins were identified during growth on the seven
`different carbon sources among 2416 ORFs encoded by B. infantis.
`Using the normalized spectrum abundance factor (NSAF) for
`each protein (representing the normalized protein quantity in
`a whole proteome of a single sample), quantitative expression
`profiles of whole proteomes were compared between cells grown
`on different carbon sources. While growth on most substrates
`exhibited similar proteome expression patterns, growth on
`galactooligosaccharides resulted in a separate cluster as witnessed
`by hierarchical cluster analysis (Figure S2). In addition,
`the
`correlation coefficients (Pearson’s product) between the GOS and
`the other proteomes were low (0.6,0.8),
`indicating that
`the
`protein expression observed during growth on GOS is significantly
`different from growth on other tested substrates (Table S4).
`
`Validation of Cell Wall Associated (CWA) Proteomics
`Most proteins observed in current shotgun whole cell proteo-
`mics experiments are cytosolic, while cell wall associated (CWA)
`proteins (both cell wall attached and membrane proteins) remain
`in the insoluble fraction with cell debris. Even if released from the
`soluble fraction, they are often missed due to the low ionization
`efficiency during MS analysis. Another constraint affecting their
`detection is their low (and/or variable) abundance by comparison
`to more readily obtained cytosolic proteins. To better understand
`the expression of CWA proteins, the insoluble fraction obtained
`after cell disruption was analyzed separately followed by the
`extensive washing with a strong denaturing agent (8 M urea/0.1M
`Tris). After removal of cytosolic proteins by washing, peptides
`from the CWA proteins were released by tryptic digestion. Protein
`localization was estimated by the quantitative ratio of
`their
`amounts in the soluble fraction and insoluble fraction.
`To validate this approach, the expression of representative
`CWA proteins such as extracellular solute binding proteins (SBPs)
`from B.
`infantis ATCC 15697 was examined [27]. These are
`common lipoproteins often associated with the transport of various
`ligands. Overall, 71 incidences of SBP expression were observed
`from the proteome of B.
`infantis grown on the seven different
`carbon sources. Among these, 23 cases of SBP expression were
`only found in the insoluble fraction (Figure 1, black bar).
`Moreover, 93% of the observed SBPs exhibited in average 2.9-
`fold higher NSAF value in the insoluble fraction by comparison to
`the soluble fraction (Figure 1). In addition to the SBPs, expression
`of other known cell wall proteins was more clearly, or solely,
`witnessed in the insoluble fraction. As shown in Table S5,
`Blon_1259, a V5/Tpx-1 family protein was not identified on the
`soluble fraction during growth on any carbon source, but it was
`one of the most abundant proteins observed in insoluble fraction.
`Also a cell surface protein involved in capsular exopolysaccharide
`synthesis
`(Blon_2082) and the NlpA lipoprotein (Blon_1721)
`exhibited 2 and 14 fold higher NSAF values in the insoluble
`fractions than that observed in the soluble fractions respectively.
`Therefore, by comparing the NSAF values of the soluble and
`insoluble protein fractions this approach provided insight into the
`cellular localization of each protein identified (Table 1 and 2). As
`shown on Table 1, 196 proteins were classified as CWA proteins
`and 93 were cytosolic (CYT) protein. However, the remaining 281
`proteins could not be conclusively classified in either cellular
`location (UI: unidentified). To further evaluate our method, the
`number of a theoretical CWA protein was predicted bioinforma-
`
`PLOS ONE | www.plosone.org
`
`3
`
`February 2013 | Volume 8 |
`
`Issue 2 | e57535
`
`Genome & Co. v. Univ. of Chicago, PGR2019-00002
`UNIV. CHICAGO EX. 2001 - 3/13
`
`

`

`Whole Cell Proteomics of B. infants
`
`Figure 1. Distribution of the NSAF ratio of each SBP between soluble and insoluble fraction (grey bars; yNSAFinsol/NSAFsol). White
`bars (soluble: left corner) and black bars (insoluble: right corner) indicate the number of SBP observed solely in soluble and insoluble fraction,
`respectively.
`doi:10.1371/journal.pone.0057535.g001
`
`tically [28]. Determination of transmembrane domains and signal
`peptides by TMHMM 2.0 [29] and the SignalP 2.0 HMM [30]
`indicated that 127 proteins are putative cell surface associated
`proteins. Among this pool of proteins, 108 were validated as cell
`wall associated by this proteomic approach. Only two of the cell
`surface associated proteins
`identified bioinformatically were
`categorized as cytosolic. In addition, 17 out of 127 theoretical
`surface proteins were found in the UI group. Thus while 281
`proteins were classified into this group by the above scoring
`criteria, the latter results on putative cell surface proteins suggests
`that the UI group is more likely to contain cytosolic proteins.
`
`Carbohydrate Metabolism
`Proteins involved in carbohydrate metabolism in B. infantis are
`summarized in Figure 2. Enzymes in the bifid shunt and glycolytic
`pathway, which are common to the utilization of various carbon
`sources, exhibited constitutive expression on the substrates used in
`this study (Figure S3). When compared to lactose-grown cells, the
`amount of each protein in these pathways varied less than two-fold
`among the different substrates. Interestingly, the genome of B.
`infantis ATCC 15697 indicates
`that
`several enzymes have
`
`isozymes. For example it contains seven genes encoding putative
`phosphoglycerate mutases, but only the expression of a single gene
`was appreciated, Blon_2152 (Figure S3).
`B.
`infantis metabolizes galactose through the Leloir pathway.
`Proteins of this pathway were observed in the proteomes of cells
`grown on all seven carbon sources, albeit their amounts varied. As
`shown in Figure 2A, galactokinase (galK: Blon_2062), Gal-1-P
`uridylyltransferase (galT: Blon_2063) and UDP-glc epimerase
`(galE: Blon_0538) were highly expressed on lactose, HMO and
`FOS. However, the alternative galE (Blon_2171) and phosphoglu-
`comutase (pgm: Blon_2184) were constitutively expressed across all
`substrates.
`N-Acetylglucosamine (GlcNAc) is one of the major constituents
`of HMO. To metabolize this monosaccharide, B. infantis possibly
`converts GlcNAc to fructose-6-P (Fru-6-P) by deacetylation
`followed by deamidation. GalNAc is another hexosamine found
`in O-linked glycans, and it could be first isomerized to GlcNAc by
`(nanE:
`an N-Acetylglucosamine
`6-phosphate
`2-epimerase
`Blon_0645). The acetyl and amine groups of GlcNAc-6-P could
`then be removed by GlcNAc-6-P deacetylase (nagA: Blon_0882)
`and glucosamine-6-P isomerase (nagB: Blon_0881), respectively.
`
`Table 1. Distribution of B. infantis proteins in cell wall or cytosolic fractions.
`
`Location
`
`Cell wall association (CWA)
`
`Cytosol (CYT)
`
`Unidentified (UI)
`
`Total
`
`Proteins identifieda
`
`Theoretical cell wall/membrane associated proteinsb
`
`196
`
`93
`
`281
`
`540
`
`108
`
`2
`
`17
`
`127
`
`aNumber of the protein for which the location was determined by the score system (See Materials and Methods).
`bTheoretical cell wall/membrane associated proteins were determined by the Signal prediction by SignalP 2.0 HMM and the transmembrane helices prediction by
`TMHMM2.0. Bioinformatic information including pfam classification was obtained from the Integrated Microbial Genomes database.
`doi:10.1371/journal.pone.0057535.t001
`
`PLOS ONE | www.plosone.org
`
`4
`
`February 2013 | Volume 8 |
`
`Issue 2 | e57535
`
`Genome & Co. v. Univ. of Chicago, PGR2019-00002
`UNIV. CHICAGO EX. 2001 - 4/13
`
`

`

`Whole Cell Proteomics of B. infants
`
`Figure 2. Central metabolic pathways reconstructed from proteomic datasets. Sugar substrates are presented inside the red boxes.
`Pathways regulated or induced by the presence of a specific sugar are indicated by colored background and their expressions on different sugars are
`presented next to the pathway as bar graphs: (a) Leloir pathway, (b) HexNAc catabolic pathway, (c) pyruvate fermentation pathway, (d) FOS/Inulin
`glycosyl hydrolase. The relative amounts of enzymes involved in the bifid shunt are presented in Figure S3. Numbers in the parenthesis next to the
`enzyme are the locus tag of each protein expressed.
`doi:10.1371/journal.pone.0057535.g002
`
`These three enzymes are expressed significantly only when B.
`infantis was cultivated on HMO, suggesting the specific induction
`of catabolic pathway for HexNAc (Figure 2B).
`While the proteins
`in the main glycolytic pathway were
`constitutively expressed, enzymes involved in pyruvate fermenta-
`tion changed their expression level depending on the carbon
`source. As shown in Figure 2C, pyruvate is reduced to lactate by
`lactate dehydrogenase (ldh: Blon_0840) with the regeneration of
`+
`NAD
`. Alternatively, pyruvate is converted to formate and acetate
`by the combination of pyruvate-formate lyase (pfl: Blon_1715)
`cleaving pyruvate to formate and acetyl CoA, and acetate kinase
`(ack: Blon_1731) converting acetyl CoA to acetate with the
`production of ATP. Expression of acetate kinase and formate C-
`acetyltransferse was consistent across all growth substrates.
`However, lactate dehydrogenase exhibited a different expression
`pattern depending on the carbon sources used. During growth on
`lactose or FOS, the amounts of LDH were 2 to 3.5-fold smaller
`than those when B.
`infantis grew on glucose, GOS, inulin and
`HMO. Interestingly, LDH was expressed 5.5-fold more on mucin
`compared to lactose. Alternative route enzymes that can produce
`acetyl CoA from pyruvate,
`i.e. pyruvate dehydrogenase or
`pyruvate oxidase, were not expressed in any of the proteomes
`(data not shown).
`
`Inulin and FOS are fructose polymers with different degrees of
`polymerization (DP). When FOS and inulin were used as carbon
`sources, a specific glycosyl hydrolase (GH) was induced (Fig-
`ure 2D). Blon_0128 is a family 13 GH annotated as a sucrose
`phosphorylase. These enzymes cleave sucrose to glucose and
`fructose-6-phosphate. The NSAF of Blon_0128 in the soluble
`fraction is higher than insoluble fraction suggesting a cytosolic
`localization. Two family 32 GH proteins
`(Blon_2056 and
`Blon_0787) were also expressed exclusively on FOS and/or
`inulin. Known activities of the family 32 GH includes inulinase
`(EC:3.2.1.7),
`levanase
`(EC:3.2.1.65),
`and
`exo-inulinase
`(EC:3.2.1.80). While Blon_0128 and Blon_2056 were expressed
`on both inulin and FOS,
`the expression of Blon_0787 was
`observed only in the proteome of FOS grown cells. The
`localization of Blon_0787 was determined in the UI group but is
`most likely a cytosolic protein.
`
`Solute Binding Proteins (SBP)
`Extracellular SBPs are typically linked to specific ABC transport
`systems consisting also in two inner membrane transporter
`components and an ATPase. The B. infantis genome contains 39
`SBPs of
`three different classes: Family 1, 3, and 5 [31]. In
`particular, Family 1 extracellular SBPs are thought
`to be
`
`PLOS ONE | www.plosone.org
`
`5
`
`February 2013 | Volume 8 |
`
`Issue 2 | e57535
`
`Genome & Co. v. Univ. of Chicago, PGR2019-00002
`UNIV. CHICAGO EX. 2001 - 5/13
`
`

`

`Whole Cell Proteomics of B. infants
`
`Figure 3. The expression of Family 1 extracellular SBPs on different carbon sources. The quantitative expression of each SBP is described
`by NSAF value. Black and gray bars indicate the NSAF values obtained in insoluble and soluble fraction, respectively. Box indicates the SBPs in the
`HMO cluster.
`doi:10.1371/journal.pone.0057535.g003
`
`responsible to the translocation of oligosaccharides [31]. As shown
`in Figure 3, different SBPs were expressed during growth of B.
`infantis on different carbohydrates. As indicated above, all Family 1
`SBPs were categorized as CWA.
`
`infantis was grown on GOS, the amounts of SBP
`When B.
`Blon_2414 were notably high, and FOS and inulin induced the
`expression of Blon_2061. In the latter case, low amounts of other
`SBPs were also observed, however, the expression of Blon_2061
`was 10,20 fold higher than the others. When HMO was added
`
`PLOS ONE | www.plosone.org
`
`6
`
`February 2013 | Volume 8 |
`
`Issue 2 | e57535
`
`Genome & Co. v. Univ. of Chicago, PGR2019-00002
`UNIV. CHICAGO EX. 2001 - 6/13
`
`

`

`on the media, SBPs Blon_2344 and Blon_2347 were mainly
`expressed. Significant expression of SBPs was not observed when
`B. infantis grew on glucose and lactose. Interestingly, mucin, whose
`glycan structure is similar to HMO, did not induce the expression
`of any of Family 1 SBPs.
`B. infantis has seven Family 3 and nine Family 5 SBPs, with
`broad affinity for di- and oligopeptides. Family 3 SBPs were
`actively expressed throughout cell growth (Figure S4). Blon_0747
`and Blon_0760 were commonly expressed regardless of carbon
`sources. Blon_2021 was induced by glucose, lactose, GOS, FOS
`and mucin but not HMO or inulin. Expression of Blon_0710 and
`Blon_2022 was observed when B. infantis was cultivated on glucose
`and lactose. Among Family 5 SBPs, Blon_0922 was highly
`expressed on all carbon sources examined. The amount of
`Blon_0922 expression was consistent and very high: it was one
`of the most highly expressed SBPs on all conditions (with the
`exception of Blon_2061 during growth on inulin). NSAF of
`Blon_0834 was high but specific in GOS proteome. Blon_0053
`and Blon_2419 appeared to be expressed constitutively across all
`substrates but at a low level.
`
`HMO Cluster I Protein Expression
`B. infantis contains a 43 kb cluster (HMO cluster I) that encodes
`genes for the catabolism of HMO ([11]; Figure 4A). During
`growth on HMO, expression of all different glycosyl hydrolases
`required for the degradation of HMO was observed. A b-
`galactosidase (Blon_2334) was expressed on all seven proteomes
`but the expression during growth on GOS was 2,3 times higher
`than that of other carbon sources (Figure 4B). The expression of
`the a-1/3,4 fucosidase Blon_2336 [32] was observed on lactose,
`FOS, inulin, and HMO indicating a more constitutive expression
`the expression of an a-sialidase
`(Figure 4C).
`Interestingly,
`Blon_2348
`[33] was
`exclusive
`to
`the HMO proteome
`(Figure 4D). The expression of a b-hexosaminidase (Blon_2355)
`was observed only during growth on HMO and inulin (Figure 4E).
`Using the scoring criteria described above, the cellular location of
`b-galactosidase and b-hexosaminidase were inconclusive however
`the NSAF of these proteins in the insoluble fraction was more than
`2 times higher than those at soluble fraction suggesting possible
`membrane association. As described in Figure 4A, putative HMO-
`related transporter SBPs Blon_2344 and Blon_2347 were adjacent
`to genes for two inner membrane transporter components, while
`SBPs Blon_2350, Blon_2351, Blon_2352, and Blon_2354 were
`positioned elsewhere in the HMO Cluster 1 without adjacent
`permease components. Protein from Blon_2344 was identified
`during growth on most of carbon sources but its amount was low
`(Figure 4F). During growth on HMO, however, expr

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket